Business Wire

UNITED-FIRST-PARTNERS

Share
UFP and Mariana Enters into Strategic Alliance, Becomes a Mid-Sized Financial Services Group with a Comprehensive Cross Assets Offering

United First Partners ("UFP"), a leading Special Situations Investment & Advisory Group is pleased to announce it has entered into a strategic alliance with the Mariana Group (“Mariana”), a leading Derivatives and Structured Products brokerage group, which is fully FCA regulated and based in London. The combination of UFP and Mariana creates a mid-sized financial services group with a strong reputation in the Equities and Derivatives space. Consequently, Mariana’s regulated entity has been renamed Mariana UFP LLP (FRN 551170) and oversee in excess of 70 professionals in London covering a broad spectrum of value added financial products and services.

This strategic alliance will add to UFP’s current offering in Equities in Europe, as Mariana is a primarily Derivatives and Structured Products brokerage operation, with a strong reputation amongst its peers. UFP and Mariana anticipate significant synergies across business lines in relation to the regulatory challenges expected in the years to come.

UFP and Mariana have upgraded their facilities and entered into new clearing arrangements in order to give Mariana UFP the tools to compete at the highest level.

In the US, UFP LLC (SEC regulated and member of FINRA and SIPC) will continue to operate as a standalone entity, although UFP and Mariana have plans to significantly expand the existing scope of activities in the region, in particular in the Derivatives segment.

Michael Hadjedj, Co-founder of UFP commented: “We are very excited by the strategic alliance we have formed with Mariana. We believe that our industry needs consolidation and Mariana UFP wants to be at the heart of it. UFP’s strong niche research offering combined with Mariana’s cross-asset execution platform and large market share in the derivatives space is a powerful combination to seize opportunities in our industry.”

Daniel Hawkins, Co-founder and CEO of Mariana added, “We are very pleased to join forces with UFP, which brings to Mariana access to a strong research franchise to complement our existing Macro-Economic and Derivative Strategy offering. We are now working towards generating synergies across the group’s business lines, and leveraging on UFP’s presence in the US. We are also preparing actively for the transition to MIFID II in Europe and feel our enlarged group is well positioned.”

About United First Partners

United First Partners (“UFP”) is a global leading Special Situations Investment & Advisory Group, offering a wide range of merchant banking and investment advisory services to institutional and private clients. These services range from sale and purchase of strategic assets to corporate finance, debt and equity capital markets and wealth management.

Our strategy and core values allowed us to build an extensive customer base including leading hedge funds, private equity funds, long-only funds, corporates, sovereign wealth funds and family offices. Our achievements, independence, unique business model and strong reputation have enabled UFP to become an attractive and reliable partner for business associates and talented professionals.

Over the past 6 years, UFP has been recognised as the #1 independent Pan European Special Situations research by industry leading survey Extel.

For further details, please visit www.utdfirst.com

About Mariana Capital

Mariana Capital Markets is a diversified, independent financial services intermediary providing bespoke advisory and strategy services. The firm was founded in 2009 to create and distribute innovative, high performance investment solutions and provide the highest quality service to our clients.

From our headquarters in the City of London, we offer global financial solutions ranging from Market Strategy and Tax Advisory to Structured Products and Estate Planning Solutions.

These services complement our status as a market leading execution venue for Cash Equities, Equity Futures and Options, Commodities, and Fixed Income products.

For further details, please visit www.marianainvestments.com

Contact:

Press Enquiries:
Sara Caniggia
+44 207 050 6803
media@utdfirst.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients6.1.2026 21:00:00 CET | Press release

Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing first-in-human study. The multi-center, open-label trial (NCT06934538) is a phase Ia/Ib study designed to evaluate safety, tolerability and preliminary clinical activity of STC-10101 in a first line setting. It will include in vivo analysis of immune and tumor dynamics during dose escalation of treatment and cohort extension to patients with unresectable locally advanced (stage IIIC, T4b) or unresectable metastatic (stage IV) MSS2 colorectal cancer (CRC). Early findings indicate that the first dose levels have been successfully completed with good overall tolerance and no-dose-limiting toxicities observed to date. “We are pleased to report that the safety profile observed to date is good and consistent with our expectations with no DLT,” said Paul Bravetti, CEO of Brenus Pharma. “Moreover, preliminar

SPIE, the International Society for Optics and Photonics, Announces Its 2026 Fellows6.1.2026 20:35:00 CET | Press release

The Society is welcoming 40 new Fellow Members from across the globe SPIE, the international society for optics and photonics, welcomes 40 Members as new Fellows of the Society in the 2026 cohort. They join their Fellow Member colleagues in being honored for their excellent technical achievements, as well as for their substantial service to the optics and photonics community and to SPIE. Fellows are Members of the Society who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. Since the Society's inception in 1955, more than 1,800 SPIE Members have become Fellows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106630672/en/ SPIE, the international society for optics and photonics, announces its 2026 Fellows This year’s inductees are high-profile leaders in academia, industry, and government, many of whom are particularly prominent in their support

Chemelex Adds Electric Heat Trace Group Ltd.’s SmartTrace Monitoring Platform to its Heat Tracing Portfolio6.1.2026 20:00:00 CET | Press release

Chemelex, a global leader in electric thermal and sensing solutions, today announced the successful completion of its acquisition of substantially all the assets and ongoing operations of Electric Heat Trace Group Ltd. (EHT Group), headquartered in Ontario, Canada. This strategic move marks an exciting start to the new year and reinforces Chemelex’s commitment to delivering smarter, data-driven solutions for industrial heat trace systems. EHT Group is a recognized innovator in heat trace management, offering advanced software, integrated controller solutions, wireless communication modules, and comprehensive field services. Its flagship platform, SmartTrace, is a robust solution available in both cloud-based and on-premises deployments that enables predictive maintenance, minimizes downtime, and provides secure remote monitoring—helping customers achieve greater reliability and operational efficiency. This endeavor will help Chemelex support greater operational efficiencies for our cus

ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA6.1.2026 19:30:00 CET | Press release

Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 statusHigh GEA burden in Asia, where BeOne holds ZIIHERA rights, signals potential broad patient impactResults to be presented as a Late-Breaking Abstract Oral Presentation at ASCO GI on January 8, 2026 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with and without PD-1 inhibitor TEVIMBRA® (tislelizumab), as a first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). These data, including the first interim overall survival (OS) analysis, will be presented as a Late-Breaking Abstract Oral Presentation (#LBA285) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) on

Siemens and NVIDIA Expand Partnership to Build the Industrial AI Operating System6.1.2026 18:07:00 CET | Press release

Through AI, Siemens and NVIDIA are reinventing the entire end-to-end industrial value chain – from design and engineering to manufacturing, production, operations, and into supply chainsSiemens and NVIDIA to build AI-accelerated portfolio including AI-native electronic design, AI native simulation as well as AI driven adaptive manufacturing and supply chainSiemens and NVIDIA to design the next generation of AI factoriesSiemens and NVIDIA to optimize operations through shared innovation CES 2026 - Siemens and NVIDIA today announced a significant expansion of their strategic partnership to bring artificial intelligence into the real world. Together, the companies aim to develop industrial and physical AI solutions that will bring AI-driven innovation to every industry and industrial workflow, as well as accelerate each others’ operations. To support development, NVIDIA will provide AI infrastructure, simulation libraries, models, frameworks and blueprints, while Siemens will commit hundr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye